Blog Archives

“MAPPING STUDIES” IN COST-UTILITY ANALYSES: NEW RECOMMENDATIONS FROM ISPOR TASK FORCE

OC.indd

Guidance for the Consistent Application of Appropriate Analytical Methods   Princeton, NJ—February 14, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good

Tagged with: , ,
Posted in Announcements, ISPOR News & Press, Value in Health

ISPOR RELEASES NEW TASK FORCE RECOMMENDATIONS FOR THE DEVELOPMENT OF CLINICIAN-REPORTED OUTCOME ASSESSMENTS

OC.indd

New Report Fills Long Standing Guidance Gap and Will Help Standardize ClinRO Assessments Princeton, NJ—February 13, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the

Tagged with: , ,
Posted in Announcements, ISPOR News & Press, Value in Health

ISPOR TASK FORCE PROVIDES RECOMMENDATIONS ON THE COLLECTION OF HEALTH-STATE UTILITY DATA IN CLINICAL STUDIES

Value in Health - Sept-Oct 2016

Five Areas of Guidance Enable Optimum Health-State Utility Measurement  Princeton, NJ—October 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force on Good Practices for Outcome Research—Measurement of Health-State Utility Values for Economic Models in Clinical Studies—has published

Tagged with: ,
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health

ISPOR 21ST ANNUAL INTERNATIONAL MEETING ISSUE PANEL CONSIDERS MCDA AS A POSSIBLE NEW PARADIGM IN HEALTH CARE DECISION MAKING

Washington, DC—May 24, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Issue Panel 12—Multi-Criteria Decision Analysis: A New Paradigm in Health Care Decision Making? What Are the Current Status, Challenges, and Opportunities?—was held this afternoon

Tagged with: , , , , , , ,
Posted in Announcements, ISPOR News & Press

ISPOR PUBLISHES TASK FORCE REPORT #2 ON MULTIPLE CRITERIA DECISION ANALYSIS

VIH-Cover_19-2

Second Report Published in March/April Issue of Value in Health Princeton, NJ—April 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report

Tagged with: , , , , , , , , , , , ,
Posted in Announcements, Brief Report, ISPOR News & Press, Value in Health

ISPOR PUBLISHES NEW TASK FORCE REPORT ON MULTIPLE CRITERIA DECISION ANALYSIS

Value in Health - January-February 2016

First of Two Reports Published in Value in Health Princeton, NJ—January 26, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) published a new Task Force Report, “Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of

Tagged with: , , ,
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health

ISPOR’s 3rd PLENARY OF 18th ANNUAL EUROPEAN CONGRESS DISCUSSES MULTI-CRITERIA DECISION ANALYSIS (MCDA)

PANEL REVIEWS RECOMMENDATIONS FROM ISPOR’s MCDA EMERGING GOOD PRACTICE TASK FORCE  Milan, Italy—November 11, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress third plenary session — Recommendations from the ISPOR Multi-Criteria Decision Analysis Emerging Good

Tagged with: , ,
Posted in Announcements, ISPOR News & Press
Categories
Follow ISPOR
RSS FeedFriend me on FacebookFollow my company on LinkedInFollow me on TwitterWatch me on YouTube